Review



bispecific antibody bnt142  (BioNTech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioNTech bispecific antibody bnt142
    Summary of on-going clinical studies of mRNA vaccines for cancer.
    Bispecific Antibody Bnt142, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bispecific+antibody+bnt142/pmc10758055-77-7-20?v=BioNTech
    Average 90 stars, based on 1 article reviews
    bispecific antibody bnt142 - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape"

    Article Title: Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape

    Journal: Theranostics

    doi: 10.7150/thno.84291

    Summary of on-going clinical studies of mRNA vaccines for cancer.
    Figure Legend Snippet: Summary of on-going clinical studies of mRNA vaccines for cancer.

    Techniques Used: Vaccines, Immunopeptidomics



    Similar Products

    bispecific antibody bnt142  (BioNTech)
    90
    BioNTech bispecific antibody bnt142
    Summary of on-going clinical studies of mRNA vaccines for cancer.
    Bispecific Antibody Bnt142, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bispecific+antibody+bnt142/pmc10758055-77-7-20?v=BioNTech
    Average 90 stars, based on 1 article reviews
    bispecific antibody bnt142 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of on-going clinical studies of mRNA vaccines for cancer.

    Journal: Theranostics

    Article Title: Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape

    doi: 10.7150/thno.84291

    Figure Lengend Snippet: Summary of on-going clinical studies of mRNA vaccines for cancer.

    Article Snippet: BNT142 , bispecific antibody, against CLDN6 and CD3 , Solid Tumor , i.v. , NCT05262530 , I/II , Recruiting , BioNTech , LNP.

    Techniques: Vaccines, Immunopeptidomics